Description

Veeva Systems Is Breaking Free From Salesforce—& AI Could Change Everything!

Veeva Systems has spent years building one of the most entrenched software franchises in life sciences, but its next phase could look considerably different from the business investors have known. The company is simultaneously completing a major strategic separation from Salesforce, moving customers onto its proprietary Vault CRM platform, and developing AI agents designed to perform labor-intensive pharmaceutical work. That combination could matter because Veeva already sits inside critical commercial, clinical, regulatory, safety, and data workflows used by pharmaceutical and biotechnology companies. Rather than competing in consumer AI or general-purpose software, Veeva is targeting highly specialized areas where regulatory complexity, domain knowledge, clean data, and customer trust can be significant barriers to entry. Its latest earnings call also suggests that customer interest in its Falcon agentic AI platform is running ahead of product readiness, even as Vault CRM adoption continues to expand.